Rakta Smart ((link)) 〈2024〉

The FDA and CE mark are notoriously strict with non-invasive diagnostics. To be marketed as a medical device, a system must prove it is not just "correlated" with lab results but is clinically equivalent. As of 2025, no non-invasive glucose monitor has received full FDA approval for insulin dosing without confirmatory finger sticks.

(Sanskrit for blood ) meets smart technology in a groundbreaking platform designed to revolutionize the way blood is collected, stored, matched, and delivered. Rakta Smart is an end-to-end IoT and AI-driven ecosystem that bridges the gap between blood banks, hospitals, donors, and emergency responders in real time. rakta smart

| Feature | Traditional Lab Test | Rakta Smart System | | :--- | :--- | :--- | | | Needle & blood draw | None (optical/spectral) | | Pain | Yes | No | | Frequency | Intermittent (weeks/months) | Continuous (real-time) | | Cost per test | Low (but lab fees add up) | High upfront, low marginal | | Data latency | Hours to days | Seconds to minutes | | Biomarker range | Very wide (100+ analytes) | Narrowing (5-20 key markers) | | Medical standard | Gold standard | Complementary (emerging) | The FDA and CE mark are notoriously strict